Samil Pharmaceutical Co.,Ltd (KRX:000520)

South Korea · Delayed Price · Currency is KRW

6,460.00

-40.00 (-0.62%)

At close: Jun 24, 2026

-35.85% (1Y)

Market Cap	137.14B -42.7%
Revenue (ttm)	210.51B -3.3%
Net Income	-36.42B
EPS	-1,714.26
Shares Out	21.23M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	143,198
Open	6,500.00
Previous Close	6,500.00
Day's Range	6,370.00 - 6,700.00
52-Week Range	6,410.00 - 12,860.00
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About KRX:000520

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea. It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products. The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophthalmic drops; and Herpecid, Forus, and Ocurasin ophthalmic ointments. Sam... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1947

Employees 583

Stock Exchange Korea Stock Exchange

Ticker Symbol 000520

Full Company Profile

Financial Performance

In 2025, KRX:000520's revenue was 210.25 billion, a decrease of -4.30% compared to the previous year's 219.70 billion. Losses were -34.66 billion, 515.8% more than in 2024.

Financial Statements